Mgr. Petra KRŇÁVKOVÁ
Telephone:
585634854
E-mail:
Workplace:
Katedra experimentální biologie
Org. unit:
Přírodovědecká fakulta
Address:
Šlechtitelů 27 A (hlavní budova)
Room number:
3.23
Profession:
Laborant
ČLÁNEK
Roshdy E., Řezníčková E., Elbadawi MM., Veselá D., Vojáčková V., Krňávková P., Kryštof V., Eldehna WM., Abe M.
First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents.
JOURNAL OF MEDICINAL CHEMISTRY.
2026.
Suárez-Rozas C., Araya-Santelices DAA., Sánchez-Velasco OA., Krňávková P., Vojáčková V., Kryštof V., Pérez EG.
Regioselective Synthesis of 9-O-Arylboldine Derivatives Using the Copper-Catalyzed Chan–Lam Reaction.
ACS Omega.
2026.
Dayal N., Řezníčková E., Hernandez DE., Peřina M., Bělíček J., Vojáčková V., Krňávková P., Bařina M., Jorda R., Sintim HO.
3H-pyrazolo[4,3-f]quinoline hinge binder, a tunable scaffold for development of novel kinase inhibitors against FLT3-driven leukemia.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY.
2026.
Eldehna WM., Tawfik HO., Veselá D., Vojáčková V., Krňávková P., Kryštof V., Abdel-Aziz HA.
Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum Cytotoxicity.
Pharmaceuticals.
2025.
Cabezas D., Delgado T., Sepúlveda G., Krňávková P., Vojáčková V., Kryštof V., Strnad M., Mella J.
3D-QSAR Design of New Bcr-Abl Inhibitors Based on Purine Scaffold and Cytotoxicity Studies on CML Cell Lines Sensitive and Resistant to Imatinib.
Pharmaceuticals.
2025.
Uživatel nepovolil zobrazení dat v Portále UP.